Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 303

1.

The effects of coxib formulary restrictions on analgesic use and cost: regional evidence from Canada.

Marshall DA, Willison DJ, Grootendorst P, LeLorier J, Maclure M, Kulin NA, Sheehy OE, Warren L, Sykora K, Rahme E.

Health Policy. 2007 Nov;84(1):1-13. Epub 2007 Jun 13.

PMID:
17570558
[PubMed - indexed for MEDLINE]
2.

Therapy switching and associated costs in elderly patients receiving COX-2 selective inhibitors or non-selective non-steroidal anti-inflammatory drugs in Quebec, Canada.

Rahme E, Toubouti Y, Hunsche E.

Rheumatology (Oxford). 2006 Jul;45(7):903-10. Epub 2006 Feb 3.

PMID:
16461440
[PubMed - indexed for MEDLINE]
Free Article
3.

An evidence-based approach to prescribing nonsteroidal antiinflammatory drugs. Third Canadian Consensus Conference.

Tannenbaum H, Bombardier C, Davis P, Russell AS; Third Canadian Consensus Conference Group.

J Rheumatol. 2006 Jan;33(1):140-57. Epub 2005 Dec 1. Erratum in: J Rheumatol. 2006 Apr;33(4):829. J Rheumatol. 2006 Feb;33(2):440.

PMID:
16331802
[PubMed - indexed for MEDLINE]
4.

Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohort.

Shireman TI, Rigler SK.

Am J Geriatr Pharmacother. 2006 Sep;4(3):210-8.

PMID:
17062321
[PubMed - indexed for MEDLINE]
5.

Prior authorization policies for selective cyclooxygenase-2 inhibitors in Medicaid: a policy review.

Fischer MA, Cheng H, Schneeweiss S, Avorn J, Solomon DH.

Med Care. 2006 Jul;44(7):658-63.

PMID:
16799360
[PubMed - indexed for MEDLINE]
6.
7.

Comparing patient access to pharmaceuticals in the UK and US.

Cohen J, Cairns C, Paquette C, Faden L.

Appl Health Econ Health Policy. 2006;5(3):177-87.

PMID:
17132032
[PubMed - indexed for MEDLINE]
8.

Coxibs versus combination NSAID and PPI therapy for chronic pain: an exploration of the risks, benefits, and costs.

Hur C, Chan AT, Tramontano AC, Gazelle GS.

Ann Pharmacother. 2006 Jun;40(6):1052-63. Epub 2006 May 23.

PMID:
16720709
[PubMed - indexed for MEDLINE]
9.

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.

Fischer MA, Schneeweiss S, Avorn J, Solomon DH.

N Engl J Med. 2004 Nov 18;351(21):2187-94.

PMID:
15548779
[PubMed - indexed for MEDLINE]
Free Article
10.

Comparison of provincial prescription drug plans and the impact on patients' annual drug expenditures.

Demers V, Melo M, Jackevicius C, Cox J, Kalavrouziotis D, Rinfret S, Humphries KH, Johansen H, Tu JV, Pilote L.

CMAJ. 2008 Feb 12;178(4):405-9. doi: 10.1503/cmaj.070587.

PMID:
18268266
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals.

Greenberg JD, Bingham CO 3rd, Abramson SB, Reed G, Kishimoto M, Hinkle K, Kremer J.

Arthritis Rheum. 2006 Aug 15;55(4):543-50.

PMID:
16874798
[PubMed - indexed for MEDLINE]
Free Article
12.

Using pharmacoeconomic analysis to make drug insurance coverage decisions.

Anis AH, Rahman T, Schechter MT.

Pharmacoeconomics. 1998 Jan;13(1 Pt 2):119-26.

PMID:
10176146
[PubMed - indexed for MEDLINE]
13.
14.

A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example.

van Staa TP, Leufkens HG, Zhang B, Smeeth L.

PLoS Med. 2009 Dec;6(12):e1000194. doi: 10.1371/journal.pmed.1000194. Epub 2009 Dec 8.

PMID:
19997499
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study.

Sebaldt RJ, Petrie A, Goldsmith CH, Marentette MA.

Am J Manag Care. 2004 Nov;10(11 Pt 1):742-50.

PMID:
15623264
[PubMed - indexed for MEDLINE]
Free Article
16.

Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs.

Mosis G, Stijnen T, Castellsague J, Dieleman JP, van der Lei J, Stricker BH, Sturkenboom MC.

Arthritis Rheum. 2006 Aug 15;55(4):537-42.

PMID:
16874797
[PubMed - indexed for MEDLINE]
Free Article
17.

Comparison of anti-infective drug use in elderly persons in Manitoba, Nova Scotia, and Saskatchewan, Canada: relationship to drug insurance reimbursement policies.

Sketris IS, Metge C, Shevchuk Y, Comeau DG, Kephart GC, Blackburn J, MacCara M, Laturnas A.

Am J Geriatr Pharmacother. 2004 Mar;2(1):24-35.

PMID:
15555476
[PubMed - indexed for MEDLINE]
18.

Utilization and cost comparison of current and optimal prescribing of nonsteroidal antiinflammatory drugs in Quebec, Canada.

Rahme E, Toubouti Y, Lelorier J.

J Rheumatol. 2006 Mar;33(3):588-96. Epub 2006 Jan 15.

PMID:
16463432
[PubMed - indexed for MEDLINE]
19.

Drug policy: making effective drugs available without bankrupting the healthcare system.

Laupacis A, Anderson G, O'Brien B.

Healthc Pap. 2002;3(1):12-30. Review.

PMID:
12811107
[PubMed - indexed for MEDLINE]
20.

The impact of reference pricing of nonsteroidal anti-inflammatory agents on the use and costs of analgesic drugs.

Grootendorst PV, Marshall JK, Holbrook AM, Dolovich LR, O'Brien BJ, Levy AR.

Health Serv Res. 2005 Oct;40(5 Pt 1):1297-317.

PMID:
16174135
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk